AbbVie has a collection of drugs that produce substantial cash flow. The company has steadily rewarded investors with dividend growth. AbbVie's dividend yield is far above the market's, and the ...
These companies have steadily grown their high-yielding dividends over the years.
AbbVie (NYSE: ABBV) is a large drug company with a somewhat unusual portfolio of products, spanning immunology (Skyrizi and Rinvoq) to esthetics (Botox). However, for many investors, the big draw is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results